{"date": "2024-10-25", "ticker": "TSLA", "triples": [["Monopar Therapeutics Inc.", "agreed with", "AstraZeneca Plc's Alexion for an exclusive worldwide license to ALXN-1840 for Wilson's disease"], ["Direxion Daily TSLA Bull 2X Shares (TSLL)", "fell", "2.93 in pre-market trading"], ["Direxion Daily TSLA Bear 1X Shares (TSLS)", "rebounded", "1.10 in pre-market trading on Friday"]]}